| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jules Dienstag | Q69897087 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| viral hepatitis | Q1983841 | ||
| P304 | page(s) | 439-462 | |
| P577 | publication date | 1983-08-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features | |
| P478 | volume | 85 |
| Q44264805 | A human T-cell clone cytotoxic for hepatocytes from patients with chronic non-A, non-B hepatitis |
| Q27472875 | Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. |
| Q52849651 | Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. |
| Q70489392 | Acute viral hepatitis: etiological spectrum in children in north India |
| Q34555204 | Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis |
| Q35815187 | Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report |
| Q38602709 | Blood transfusion and hepatitis: still a threat? |
| Q27473535 | CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C |
| Q36981033 | Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies |
| Q34729109 | Chronic viral diseases |
| Q35236549 | Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan |
| Q35219300 | Cloning of a cDNA associated with acute and chronic hepatitis C infection generated from patients serum RNA. |
| Q43692657 | Cloning of serum RNA associated with hepatitis C infection suggesting heterogeneity of the agent(s) responsible for the infection |
| Q45328308 | Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C. |
| Q34073858 | Current status of hepatitis C in Canada. |
| Q39604855 | Delta and non-A, non-B hepatitis viruses. |
| Q67690697 | Detection of 2′,5′ oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage |
| Q27488778 | Detection of antibodies to hepatitis C virus in U.S. blood donors |
| Q42987978 | Detection of hepatitis C virus RNA in sera and liver tissues of non-A, non-B hepatitis patients using the polymerase chain reaction |
| Q42986013 | Discrepant results of different tests for antibodies to hepatitis C in children with malignant diseases and in patients on renal replacement therapy |
| Q46308416 | Drs. Grégoire and Smiley reply |
| Q42981086 | Early appearance and biphasic kinetics of IgG antibody against hepatitis C virus protein C100-3 |
| Q43048309 | Effects of interferon-alpha on serum hepatitis C virus in patients with chronic hepatitis C. |
| Q27473016 | Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA |
| Q30448796 | Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions |
| Q39255238 | Epidemiology and clinical outcome of hepatitis D virus infection in Turkey |
| Q33851211 | Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus |
| Q45833765 | Fulminant NANB hepatitis in a patient with AIDS: a possible demonstration of direct hepatic damage by the virus/es involved? |
| Q70264235 | Fulminant hepatic failure |
| Q35357332 | Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus |
| Q40305087 | Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein |
| Q42338358 | HEPATITIS C VIRUS: WHERE IS IT LEADING US? |
| Q36575649 | Hepatitis A, B and nAnB: The Viruses and their Prevention. |
| Q33929132 | Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management |
| Q27485419 | Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses |
| Q68264325 | Hepatitis C virus |
| Q27486078 | Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV |
| Q37887627 | Hepatitis C virus and transfusion transmitted liver disease: review |
| Q42980810 | Hepatitis C virus infection in patients with acute hepatitis B |
| Q29620772 | Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups |
| Q27469295 | Hepatitis C virus. A review |
| Q42981065 | Hepatitis C virus: a historical perspective |
| Q35112094 | Hepatitis viruses: changing patterns of human disease |
| Q37334699 | Intensive liver care and management of acute hepatic failure |
| Q60211106 | Interferon for chronic hepatitis C in patients cured of malignancy |
| Q40354772 | Internal medicine: non-a, non-B hepatitis |
| Q42984591 | Intrafamilial transmission of hepatitis C. |
| Q72400571 | Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha |
| Q73304044 | Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection |
| Q27860811 | Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis |
| Q38709563 | Morbidity and mortality of portal hypertension. |
| Q33498295 | Morbidity of chronic hepatitis C as seen in a tertiary care medical center |
| Q36723777 | Non A, non B hepatitis in the aged |
| Q47911308 | Non-A, non-B fulminant viral hepatitis in France in returnees from Asia and Africa |
| Q27469293 | Non-A, non-B hepatitis |
| Q52267163 | Non-A, non-B hepatitis; factors involved in progression to chronicity. |
| Q39827604 | Occupational liver injury. Present state of knowledge and future perspective |
| Q35188010 | Perioperative haemotherapy: II. Risks and complications of blood transfusion |
| Q43003818 | Post-transfusion hepatitis after cardiac surgery. |
| Q45981437 | Post-transfusion hepatitis after cardiac surgery. |
| Q44758926 | Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs |
| Q35893145 | Prevalence of antibody to hepatitis C virus in an isolated Canadian Inuit settlement |
| Q42981438 | Prevalence of hepatitis C virus antibody in a liver transplantation population |
| Q44507250 | Prevalence of hepatitis C virus infection among female prostitutes in Fukuoka, Japan |
| Q42274990 | Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases |
| Q35707243 | Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis |
| Q43048315 | Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM. |
| Q42982650 | Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels |
| Q42245958 | Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection |
| Q71623799 | Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion |
| Q43594861 | Serological diagnosis of acute viral hepatitis. |
| Q72795464 | Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha |
| Q92856328 | The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On! |
| Q43982980 | Therapy of hepatitis C |
| Q45156141 | Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response |
| Q44202794 | Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report |
| Q68008537 | Viral hepatitis |
| Q93535905 | Viral hepatitis |
| Q52849703 | [Hepatitis non-A, non-B: epidemiologic, clinical, serologic and morphologic aspects]. |
Search more.